(VIANEWS) – Shares of VISTIN PHARMA (Oslo Børs All-share Index_GI: VISTN.OL) jumped by a staggering 12.91% to kr18.80 at 10:41 EST on Friday, following the last session’s upward trend. Oslo Børs All-share Index_GI is sliding 0.78% to kr1,405.92, after five consecutive sessions in a row of losses. This seems, as yet, a somewhat down trend trading session today.
About VISTIN PHARMA
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin hydrochloride APIs and direct compressive granulates for the pharmaceutical industry. The company was incorporated in 2015 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr0.96.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 19.58. Meaning, the purchaser of the share is investing kr19.58 for every norwegian krone of annual earnings.
Volume
Today’s last reported volume for VISTIN PHARMA is 58691 which is 298.95% above its average volume of 14711.
Volatility
VISTIN PHARMA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.61%, a negative 0.13%, and a positive 2.18%.
VISTIN PHARMA’s highest amplitude of average volatility was 2.76% (last week), 1.15% (last month), and 2.18% (last quarter).
More news about VISTIN PHARMA (VISTN.OL).
